The frequency of high PD-L1 expression is low in lung adenocarcinoma patients from Northeast Brazil

• Үндсэн зохиолчид: Antonio V. Alves da Silva (Зохиогч), Francisco Martins Neto (Зохиогч), Ana Claudia da Silva M. de Oliveira (Зохиогч), Benedito A. Carneiro (Зохиогч), Marclesson Alves (Зохиогч), Cleto Dantas Nogueira (Зохиогч), Fabio Tavora (Зохиогч)
• Формат: Ном
• Хэвлэсэн: BMC, 2019-02-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Abstract Background As Immune checkpoint inhibitors (ICPIs) are changing the standard-care in lung cancer with good clinical activities and durable responses, its indication must be based on the appropriate patient selection once only a fraction of patients has a response to these costly drugs. In l...